PLASMAFLO OP OP-05W(A) N/A

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2019-03-04 for PLASMAFLO OP OP-05W(A) N/A manufactured by Asahi Kasei Medical Co., Ltd..

Event Text Entries

[137654688] This incident occurred in (b)(6) and is reported to fda according to the requirement. Plasmaflo op-08w is similar product of plasmaflo op-05w(a) marketed in us. The used product and information of lot number were not available because the product was disposed in the healthcare facility. Consequently, the root cause of the event could not be identified as only the insufficient information was available. Plasmaflo op is used as plasma separator and plasma component is further separated by plasorba brs, which was concomitantly used for the patients. Pulmonary alveolar hemorrhage which caused the patient's death is not described in the instructions for use (ifu) of plasmaflo op. Physician considered that this patient's death was mainly caused by the aggravation of patient's complication of serious liver failure, pulmonary alveolar haemorrhage. However, since the adverse event occurred during the treatment, the causal relationship between the patient's pulmonary alveolar haemorrhage and plasmaflo op could not be denied. We considered that the pulmonary alveolar haemorrhage was serious, and that the causal relationship between plasmaflo op and the pulmonary alveolar haemorrhaget could not be denied because the adverse event occurred during the treatment with op-08w and plasorba brs. This case was obtained from the doctor's inquiry to us. As the doctor is reluctant to our further investigation, the follow-up investigation like the patient's underlying disease and the cause of the this event is not possible. Although this adverse event is not written in the ifu of op, as this case is the first time to receive as op, so we will carefully continue to monitor and to be vigilant for the trend of occurrence of this kind of adverse events.
Patient Sequence No: 1, Text Type: N, H10


[137654689] A patient was in the condition of postoperative hepatic failure in (b)(6). The patient's bilirubin value began to increase around the second day after the operation, although the laboratory data of the patient's coagulation factor was in the lower level, this patient's apheresis treatment with plasmflo op-08w, used as plasma separator and similar product of op-05w(a) sold in us, and plasorba brs, absorptive removal column of bilirubin and bile acid, to absorb bilirubin was started. The situation about the first treatment was unknown. In the end of (b)(6) 2018, the patient developed the pulmonary alveolar hemorrhage in the second treatment with op-08w and plasorba brs, and died after its treatment. The detail information about the medical treatment of the adverse event was unknown.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8010002-2019-00010
MDR Report Key8385341
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2019-03-04
Date of Report2019-02-15
Date of Event2018-11-30
Date Mfgr Received2019-02-15
Date Added to Maude2019-03-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag0
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. AKITAKE YAMASHITA
Manufacturer Street1-1-2 YURAKUCHO, CHIYODA-KU
Manufacturer CityTOKYO 100-0006
Manufacturer CountryJA
Manufacturer Postal100-0006
Manufacturer G1ASAHI KASEI MEDICAL MT CORP.
Manufacturer StreetOITA WORKS 2111-2 OAZA SATO
Manufacturer CityOITA-SHI, OITA 870-0396
Manufacturer CountryJA
Manufacturer Postal Code870-0396
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePLASMAFLO OP
Generic NamePLASMA SEPARATOR
Product CodeMDP
Date Received2019-03-04
Model NumberOP-05W(A)
Catalog NumberN/A
Lot NumberN/A
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerASAHI KASEI MEDICAL CO., LTD.
Manufacturer Address1-1-2 YURAKUCHO CHIYODA-KU TOKYO 100-0006 JA 100-0006


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2019-03-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.